Empty Capsules Market (2022-2029)
The Empty Capsules Market is expected to reach $4.47 billion by 2029, at a CAGR of 6.7% from 2022 to 2029.
- Published
- Sep 2022
- Pages
- 180
- Format
- PDF + Excel
- Report ID
- MRHC - 104659
- Base year
- 2021
- 2029 · FORECAST
- $4.47B
- 2029
- $4.47B
- CAGR 2022–2029
- 6.7%
2021 baseline · 2022–2029 forecast at 6.7% CAGR · hover a bar for the value
Key highlights
Based on Product Type, the Gelatin Segment is Expected to Account for the Largest Market Share in 2022
Based on Functionality, the Immediate-release Capsules Segment is Slated to Register the Highest CAGR Over the Forecast Period
Based on Application, the Antibiotic & Antibacterial Drugs Segment is Expected to Dominate the Market in 2022
Based on End User, the Pharmaceutical Companies Segment is Expected to Account for the Largest Market Share in 2022
Asia-Pacific: Fastest-growing Regional Market
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2021 |
| Estimated Year | 2022 |
| Forecast Period | 2022–2029 |
| Market Size (2029) | USD 4.47 billion |
| CAGR (2022–2029) | 6.7% |
| Format | PDF, Excel & Cloud Portal · 180 pages |
| Segments Covered | By Product Type: Gelatin Capsules Bovine Gelatin Capsules, Porcine Gelatin Capsules, Other Gelatin Capsules, Hydroxypropyl Methylcellulose (HPMC) Capsules, Pullulan & Starch Capsules · By Functionality: Immediate-release Capsules, Sustained-release Capsules, Delayed-release Capsules · By Application: Antibiotic & Antibacterial Drugs, Dietary Supplements, Antacids & Anti-flatulent Preparations, Antianemic Preparations, Anti-inflammatory Drugs, Cardiovascular Therapy Drugs, Cough & Cold Drug Preparations, Other Applications · By End User: Pharmaceutical Companies, Neutraceutical Companies, Cosmeceutical Companies, Research Laboratories · By Type: Gelatin Capsule, Non-gelatin |
| Countries Covered | Europe (RoE), Asia-Pacific (RoAPAC) |
| Key Companies | CapsCanada Corporation, Qingdao Yiqing Medicinal Capsules Co., Ltd., HealthCaps India Ltd., Goerlich Pharma GmbH, Bright Pharma Caps Inc., Suheung Co. Ltd., Roxlor LLC |
Report overview
Segments covered: product type, functionality, application, end user, type. Regions: Europe, Asia-Pacific.
Capsules are the solid dosage form in which drugs or substances are enclosed. Empty capsules are used for the oral dosage form. It is used to store powdered APIs (active pharmaceutical ingredients), herbal powders, and vitamin supplements. Most pharmaceutical manufacturers use empty capsules to prepare therapeutic drugs, which drives their market demand. Furthermore, growing investments in emerging economies to manufacture pharmaceuticals offer significant opportunities for the growth of this market.
The COVID-19 pandemic positively impacted the empty capsules market. The pandemic highlighted the importance of consuming healthy diets and living healthy lifestyles to maintain immunity. Thus, the consumption of herbal and supplementary capsules increased significantly, boosting the demand for nutraceuticals. The increased demand for nutraceuticals subsequently drove the demand for empty capsules. Furthermore, research centers and pharmaceutical & biotechnology companies continuously focused on developing therapies for COVID-19, which increased the demand for capsules.
However, as the manufacturing of empty capsules is majorly concentrated in countries such as China and India, there were temporary disruptions in the supply chain due to nationwide lockdowns, which adversely affected the market's growth.
The adoption of dietary supplements and nutraceuticals is rising among consumers globally. The adoption of healthy lifestyles is driving the growth of the dietary supplements market, which drives the demand for empty capsules. Furthermore, the rising disposable incomes among consumers and the growing accessibility to supplements further drive the market's growth.
Empty capsules are empty shells made from special film-forming materials such as starch, gelatin, and pullulan. Although tablets are the most preferred alternatives for consumption among the solid dosage forms, the adoption of capsules is also significantly high. Capsules have various advantages over tablets, such as faster dissolution time, better bio-absorption, ease of swallowing, and no bitter taste after consumption. These benefits increase the adoption of empty capsules for producing antacids, anti-bacterial therapies, and cold & cough medications.
Report infographic
Table of contents
12 chapters · 93 sections · 180 pages · click to expandSegmental analysis
| Segment | Largest share (2022) | Fastest growth (2022–2029) |
|---|---|---|
| By Product Type | Gelatin | — |
| By Functionality | — | Immediate-release capsules |
| By Application | Antibiotic & Antibacterial Drugs | — |
| By End User | Pharmaceutical Companies | — |
By Product Type
- The Gelatin Segment is Expected to Account for the Largest Market Share in 2022
- Gelatin has been traditionally used in the manufacturing of capsules.
- Factors such as easy availability of raw materials, low cost, and easy manufacturing processes drive the adoption of gelatin in pharmaceutical manufacturing.
- The need to reduce operational costs in the pharmaceutical sector has resulted in companies adopting cost-effective alternatives such as gelatin for manufacturing capsules.
By Functionality
- The immediate-release capsules segment is slated to register the highest CAGR during the forecast period.
- Immediate-release capsules take immediate effect after consumption.
- Thus, these capsules are used in the production of various medical products such as antacids and pain relievers.
- These factors drive the global demand for immediate-release capsules.
By Application
- The Antibiotic & Antibacterial Drugs Segment is Expected to Dominate the Market in 2022
- Antibiotics and anti-bacterial drugs are used to prevent or treat some types of microbial infections.
- The rising prevalence of infectious diseases, the high demand for antibiotics from low & middle-income countries, and the increasing investments in R&D activities by major pharmaceutical companies are the key factors driving the empty capsules market for the manufacturing of antibiotics and anti-bacterial preparations.
By End User
- The pharmaceutical companies segment is expected to account for the largest market share due to the high volume of commercial production by pharmaceutical companies.
Geographic analysis
Asia-Pacific
Fastest growthThe growth of this regional market is driven by the increasing investments in the pharmaceutical sector, expansions of pharmaceutical manufacturing plants, wide availability of raw materials, and the increasing collaborations between raw material suppliers and pharmaceutical companies. Asia-Pacific: Fastest-growing Regional Market
Competitive landscape
- CapsCanada Corporation
- Qingdao Yiqing Medicinal Capsules Co., Ltd.
- HealthCaps India Ltd.
- Goerlich Pharma GmbH
- Bright Pharma Caps Inc.
- Suheung Co. Ltd.
- Roxlor LLC
Frequently asked questions
This study offers a detailed assessment of the market sizes & forecasts of the empty capsules market based on product type, functionality, application, and end user. This study also provides the value analysis of various segments and subsegments of the empty capsules market at the regional and country levels.
Cite this report
Meticulous Research. (2022). Empty Capsules Market - Global Opportunity Analysis And Industry Forecast (2022-2029) (Report No. MRHC - 104659). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/empty-capsules-market-5344